Invest in Innovation
AVEX.AI Tracker Certificate
Offers investors exposure to the AVEX token.
A Revolutionary New Instrument for Investors
Gain Exposure to Blockchain-Derived Health Industry Assets through a Familiar Product
AVEX.AI is the first-ever tracker certificate issued via Swiss ISIN designed to participate in the world’s pioneering dynamic tokenized medical care market.
It is a structured product following Swiss guidelines, using a securitization pathway to introduce ISIN-wrapped digital tokens to traditional investors.
AVEX.AI offers a secure way of participating in blockchain-derived assets, which ensures that investors can take advantage of the new opportunities in this exponential space using a product that offers a high degree of ease and familiarity.
With AVEX.AI, there is no necessary learning curve or technological specialization required to invest in health industry crypto assets. It combines the cutting-edge opportunity of blockchain with the simplicity and security of classic investment.
AVEX.AI Product Profile
The AVEX token is the blockchain-derived asset that allows consumers and other participants in the Biospheres network to transact within the Biospheres platform. It is designed to capture the value of the health innovation sector within a closed ecosystem. Biospheres is a borderless marketplace that accommodates billions of dollars in leading-edge health science, biotech products, and medical offerings that offer solutions to some of the world’s most pressing health problems. The platform aims to address under- or unfunded projects looking to solve growing global concerns like Alzheimer’s Disease and cancer, rare diseases such as Amyotrophic Lateral Sclerosis (ALS), or resultant complications of medical treatments like organ rejection after transplantation, to name a few.
The AVEX token is also the first new digital asset to launch through a structured product available via Swiss ISIN. Opportunities for new token offerings were previously exclusive to a highly technical community that generated unprecedented returns for many early investors. With this new alternative investment product, we make it as easy as buying a stock as a means to introduce a new investor market into crypto and reduce the risks that have been associated with other differently-designed crypto offerings.
AVEX.AI Tracker Certificate on Aevolve Token (AVEX)
Tracker-Certificate (Code 1300) of the Swiss Derivative Map, as amended from time to time by the Swiss Structured Products Association (www.svsp-verband.ch)
AVEX token is the sole and exclusive crypto asset that is used to purchase unique health tech products in BIOSPHERES, a tokenized marketplace for health innovation offerings.
USD 100’000’000.00 (Maximal Amount)
Minimum Trade Size
10 Certificates and 1 Certificate thereafter
To Be Announced
FP ISSUER LIMITED (GUERNSEY)
Merging Traditional Finance with Health Innovation
AVEX.AI is a classic investment that has all the properties of legal security. This familiarity avoids technological mishaps in large-scale investing, especially for those who have not yet gone into blockchain-derived assets. Storage, custody, escrow, digital security are covered in the management of the underlying, and investors do not need to tackle issues such as self-management of private keys. One simply invests in a tracker certificate that follows the recognizable rules of the stock market.
AVEX.AI is a simple product that requires no learning curve or technological shift. Investors that are accustomed to traditional investment methods will find it an ideal entry point into the new, dynamic world of crypto markets.
This is a first-in-the-world financial product that gives traditional financial managers exposure to a crypto token at its earliest stage. The regulatory and compliance landscape for crypto assets is unclear and uncertain. This structured asset helps to break through the fear, uncertainty, and doubt associated with new technology.
This investment tool is geared towards social good, sustainability, and future success by being a well-rounded mechanism that extends beyond marketing and financial performance. It was designed with a social impact in mind.
Social benefits were ingrained in the business model from the start. The project benefits large communities by driving an active donation market. The same marketplace that offers treatment reservations allows public donations to worthy causes in the health sector.
Today, ESG (Environmental, Social, and Governance) Investing is considered an additional metric for investment strength. This model points to a more sustainable type of investment, relying on transformative social contributions that outlast short-term marketing and price-boosting efforts, and adding strong balance to a portfolio.
THE NEW PATH TO PATIENT-DRIVEN TREATMENTS AND CURES
Aevolve is a protocol that supports medical innovations from R&D stages to full-scale commercialization, by connecting patients, investors, and scientific innovators.
FOR PATIENTS AND INNOVATORS
This innovation marketplace connects patients and the global community directly with scientific innovators and experts from all over the world to address various stages of the innovation life cycle.
INVESTOR ACCESS TO A BILLION-DOLLAR ECOSYSTEM
This new asset class provides exposure to opportunities in blockchain, free of the risks associated with previous token offerings. Coming soon to the the SIX Swiss Stock Exchange.
AVEX Token & The Aevolve Protocol
Cutting-edge medical science meets blockchain-driven technology to create new opportunities to drive innovation.